Post-Marketing Studies
- 1 January 1998
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 19 (5) , 343-353
- https://doi.org/10.2165/00002018-199819050-00002
Abstract
The Drug Safety Research Unit (DSRU) is the centre for prescription-event monitoring (PEM) in England. PEM studies are noninterventional observational cohort studies which monitor the safety of newly...Keywords
This publication has 24 references indexed in Scilit:
- The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in EnglandBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Unlicensed and off label drug use in paediatric wards: prospective studyBMJ, 1998
- A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studiesPharmacoepidemiology and Drug Safety, 1997
- Principles of Signal Detection in PharmacovigilanceDrug Safety, 1997
- General practice postal surveys: a questionnaire too far?BMJ, 1996
- Newer Antipsychotic DrugsDrugs, 1993
- United Kingdom Product Licence applications involving new active substances, 1987‐1989: their fate after appeals.British Journal of Clinical Pharmacology, 1993
- Review of company postmarketing surveillance studies.BMJ, 1992
- Prescription-event monitoring: Methodology and recent progressJournal of Clinical Epidemiology, 1990
- Guidelines on postmarketing surveillance. Joint committee of ABPI, BMA, CSM, and RCGP.1988